Cardiomyopathy Trial, Recruiting NCT06730607 Sponsor: Centro Medico Teknon Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06730607
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who were diagnosed with myocarditis (inflammation of the heart muscle) more than 6 months before joining the study
  • People who have had a specific type of heart scan (called a CMR scan) performed more than 6 months after their myocarditis diagnosis
  • People who are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • People who are under 18 years of age
  • People who are pregnant
  • People who have other heart structural problems (such as heart conditions present from birth or other non-related heart disease)
  • People who currently have active myocarditis (currently ongoing heart inflammation)
  • People whose myocarditis diagnosis was less than 6 months ago
  • People who have previously had documented serious heart rhythm problems originating in the lower chambers of the heart
  • People for whom the required heart scan (called an LGE-CMR scan) is not possible or is medically inadvisable
  • People who are currently taking part in other experimental treatment studies
  • People whose medical situation, location, or personal circumstances would make taking part in the study difficult, or who are unable or unwilling to sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centro Medico Teknon
Registry
ClinicalTrials.gov
Start date
2 December 2024
Est. completion
30 December 2026

Where this trial is recruiting

🇮🇹 Italy 🇪🇸 Spain

Primary endpoints

Number of patients presenting one of sudden cardiac death, sustained ventricular arrhythmia, or defibrillator therapy.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov